Transplantation Journals News

New Impact Factors just released for Transplantation and Transplantation Direct

New Impact Factor: 6.2

Jeremy R. Chapman
Editor-in-Chief -
Transplantation Journals

New Impact Factor: 2.3

Executive Editor

TTS is proud to announce these two metrics reflecting the Transplantation journals continued increase in impact and influence.

This year Transplantation’s impact factor has again risen significantly (from 5.4 to 6.2) at a time when the impact factors of almost all journals in the transplantation field have dropped.

Transplantation Direct has received an Impact Factor for the first time and has jumped in at 2.3, ahead of many established journals in the field, and the highest of the 6 new entrants. This tremendous success is the result of years of hard work and the contributions of many. The Editorial Boards number around 140 people and the reviewer boards represent the global membership of TTS and the Sections.

Led by our Editor-in-Chief Jeremy Chapman and the Executive Editorial Team, Transplantation relies on nine deputy editors spread across the world and nearly one hundred specialist Associate Editors who ensure expert assessment of all submissions.

Edward Geissler leads Transplantation Direct supported by a team of Deputy Editors who come from TTS Sections - ISODP, IPITA and ISUTx - that have adopted Transplantation Direct as their official journal.

These remarkable achievements reflect the excellence and significance of our publications in the field. We congratulate these dedicated teams and thank all our contributors and authors who share their important work globally through the Transplantation journals.

Transplantation Editorial Board

Transplantation Direct Editorial Board

Executive Editors

Carla Baan
Executive Editor (Basic Science)
Jonathan Bromberg
Executive Editor (Clinical)
Bruce Kaplan
Executive Editor
(Stats / Bioinformatics)
Jean C. Emond
Executive Editor (Liver)
Stefan G. Tullius
Executive Editor (Special Feature)

Deputy Editors

Daniel C. Brennan
Anita S. Chong
Francois Durand
Peter Friend
Fadi Issa
Christophe Legendre
Nancy Kwan Man
Kazunari Tanabe
Helio Tedesco Silva, Jr.

Social media

Social Media Editor
Transplantation Journals

Deputy Editors

Melena Bellin
Mats Brännström
David Briscoe
Jonathan Fridell
Guenter Kirste
Maureen Meade
Jon Odorico

View entire Editorial Board

Transplantation Direct
View entire Editorial Board

SPLIT 2023 - Abtract Submission will stay open over the weekend (Deadline was June 30)!

Full Program is now Available on our website

Submit an abstract and apply for an award!

Contribute to the program by submitting your abstract to this year’s SPLIT Annual Meeting. The top three abstracts will receive an award and authors will have the opportunity to give a 10 min oral presentation during the meeting.

Award winners will have the opportunity to present their research in either poster or oral presentation, receive free SPLIT Annual Meeting registration, a grant for reimbursable travel expenses up to $1000 and networking opportunities. We are offering two types of awards

  • SPLIT – TTS Travel Grants for Trainees, Junior Faculty, and Multi-disciplinary Team Members.
  • Albireo, an Ipsen Company, and Mirum Travel Grants for Medical Students, Pediatrics Residents, Surgery Residents and Pediatric Gastroenterology fellows identifying as Underrepresented in Medicine

Transplantation Journals Highlighted Articles

Transplantation - Highlighted Tweets

Amplified Natural Killer Cell Activity and Attenuated Regulatory T-cell Function Are Determinants for Corneal Alloimmunity in Very Young Mice
Corneal transplantation outcomes are generally less favorable in young children compared with adults. The purpose of this study was to determine the immunological mechanisms underlying this difference.
Vaccine-preventable Disease After Transplantation: A Missed Opportunity
Prevention of infectious complications in the transplanted patient is a cornerstone of care in this vulnerable population. After transplantation, detailed preemptive and prophylactic protocols are in place and have markedly reduced some infectious diseases, primarily with traditional opportunistic pathogens such as cytomegalovirus and Toxoplasma gondii.1 However, a great opportunity to optimally prepare all candidates for immunosuppression is often missed: assessing and updating the vaccination status before transplantation.

Transplantation Direct - Highlighted Tweets

Tissue and Cell Donation: Recommendations From an International Consensus Forum
Organ, tissue, and cell donation and transplantation legislation and policies vary substantially worldwide, as do performance outcomes in various jurisdictions. Our objective was to create expert, consensus guidance that links evidence and ethical concepts to legislative and policy reform for tissue and cell donation and transplantation systems.
Baseline Ethical Principles and a Framework for Evaluation of Policies: Recommendations From an International Consensus Forum
To maintain public trust and integrity in organ and tissue donation and transplantation (OTDT), policymakers, governments, clinical leaders, and decision-makers must ensure that policies proposed to increase donation and transplant activity satisfy baseline ethical principles established by international agreement, declaration, and resolution. This article describes the output of the Baseline Ethical Domain group of an international forum designed to guide stakeholders in considering these aspects of their system.

IPITA-IXA-CTRMS Joint Congress - Registration Now Open!

Early-bird Registration Deadline: July 24
Take advantage of the reduced fees!

The International Pancreas and Islet Transplant Association (IPITA), the International Xenotransplantation Association (IXA), and the Cell Transplant and Regenerative Medicine Society (CTRMS) reaffirm their strong partnership as leaders in transplantation and promise to provide an outstanding and innovative program.

Leading experts and opinion leaders from all over the world will present the latest data and address important needs in clinical and experimental transplant therapy. Specific sessions will be devoted to hot research in whole-organ pancreas transplantation, islet transplantation, stem cell therapy, xenotransplantation and transplant biology.

We are expecting close to 600 delegates from all over the world.

We look forward to welcoming YOU to San Diego!

In Case You Missed It ... Recent Recordings

A special thanks to our important partners AST and ESOT for making this meeting a tremendous success!

List of Recordings

Plenary Sessions

Welcome Address
30 April 2023  /  15:30 - 16:40

Cellular engineering for transplantation
01 May 2023  /  08:00 - 09:20

Environmental modifiers of alloimmune response
01 May 2023  /  10:50 - 12:20

Regenerative medicine: improve whats not good enough or build from scratch?
01 May 2023  /  13:40 - 15:10

B cells and antibodies as immune regulators: from bench to bedside
02 May 2023  /  08:00 - 09:20

Patient Perspectives
02 May 2023  /  11:00 - 12:30

Mentoring Presentation
01 May 2023  /  12:20 - 13:40

From survive to thrive: the power of mentorship
Presenter: Lorna Marson, United Kingdom

Engineered T cells in transplantation
02 May 2023  /  12:30 - 14:00

Bioengineering for transplantation
02 May 2023  /  14:25 - 15:30

Women in Transplantation Networking Session
02 May 2023  /  17:30 - 18:30

Influence of Sex and Gender in Transplantation
03 May 2023  /  08:00 - 09:20

New perspectives in innate/ILC immunity and tissue-resident leukocytes
03 May 2023  /  11:00 - 12:35

Abstract Sessions

Abstracts Session 1
30 April 2023  /  16:40 - 18:00

Abstracts Session 2
01 May 2023  /  09:20 - 10:20

Abstracts Session 3
02 May 2023  /  09:20 - 10:30

Abstracts Session 4
02 May 2023  /  14:00 - 14:25

Abstracts Session 5
02 May 2023  /  16:15 - 17:20

Abstracts Session 6
03 May 2023  /  09:20 - 10:10

Abstracts Session 7
03 May 2023  /  10:30 - 11:00

Thank you message

Dear Colleagues,

With the conclusion of the 18th Congress of the Middle East Society for Organ Transplantation (MESOT 2023) that took place on May 24-26, 2023, I would like to express my sincere appreciation for those who attended and contributied at the meeting.

From its inception, the goals of MESOT have been to encourage the development of scientifically and ethically superior organ transplantation activities across the globe. Therefore, The MESOT International Congress is the major international transplant congress and attracts a broad range of health professionals.

MESOT 2023 Congress which was endorsed by The Transplantation Society (TTS), The Turkish Transplantation Society (TOND) and The Turkic World Transplantation Society (TDTD) proved to be a great success, with high positive feedback from all who were in attendance. The total number of registrations for the MESOT Congress was 320 from 38 countries. A total of 55 Invited Lectures, 38 Oral and 116 Poster Presentations were scheduled for the congress.

The scientific program incorporated a wide range of topics designed to provide an innovative and comprehensive overview of the latest developments in the field of experimental and clinical transplantation in the Middle East and the world. I hope it has provided valuable insights for our colleagues in the transplant field across the globe.

Once again, thank you for your support it was an honor to host this important Congress.


Mehmet Haberal, MD, FACS (Hon), FICS (Hon),
FASA (Hon), FIMSA (Hon), Hon FRCS (Glasg)
Founder and Past-President, MESOT
Congress Chair, 18th Congress of the Middle East Society for Organ Transplantation

TTS Members Only.
MESOT Members and Attendees will be provided access soon.

In the News 



Staff Directory


The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6